Delivery Order SPE2DB22D6029-SPE2DB24FU0WD
- Not listed
- The federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $18,893.70, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 6, 2025. The contract is not set-aside and allows for open...
- This federal contract award, valued at $1,195.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566296293 ONDANSETRON 4 MG/5 ML SOLN CUP UD 5ML, with a completion date of November 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
- This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The $5,342.92 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 19, 2024. The contract has an ultimate completion date of December 20, 2024 and is not designated with any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract, valued at $19,360.08, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,707.36, is a delivery order awarded by the Defense Logistics Agency (DLA) for the supply of 4567253171 - ONDANSETRON 4 MG/5 ML SOLN CUP UD 5ML. The contract has a firm fixed price pricing type and a completion date of February 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,423.32 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 23, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of 4566504323 units of ONDANSETRON HCL 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,537.08 and is a firm-fixed-price delivery order, with a completion date of November 21, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is not designated as a set-aside contract. Amerisourcebergen...
- This federal contract award is for the delivery of 4565844525 - ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $6,286.86. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation. The contract has an ultimate completion date of September 18, 2024. Amerisourcebergen is a significant supplier of...
- This federal contract award, valued at $3,661.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for 4568143819 - ONDANSETRON ODT 4 MG TABLET 30S, with a completion date of May 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This contract award is for the delivery of 4563471741 ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,250.28, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, and is due for completion by January 30, 2024. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00,...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU0WDDelivery Order
This federal contract award is for the delivery of ONDANSETRON 4 MG/5 ML SOLN CUP UD 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $1,253.13 and an ultimate completion date of May 8, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/7/24 |